glp 1 agonist effects Exploring the Side of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning The cardiovascular effects of GLP-1

3 Evolution of GLP-1-based therapeutics 3.1 First-generation GLP-1RAs The development of GLP-1 receptor agonists stemmed from the significant finding that natural GLP-1 had an exceptionally short half-life of about 1.5 to 5 min, due to its rapid degradation by the enzyme DPP-4 (Campbell and Drucker 2013) (Fig

Emerging clinical evidence, such as the STEP-HFpEF and FLOW trials, underscores the efficacy of GLP-1RAs in alleviating symptoms, improving quality of life, and slowing disease progression in HFpEF patients

Therefore, GLP-1 is a multifunction hormone with wide pharmacological potential

Tailored dosage adjustments based on your individual response

Diabetologia (1993) 36:7414

J Hypertens 2006;24:11871192